Related Experiment Video
Updated: Jul 15, 2025

08:25
Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
Published on: April 11, 2018
15.3K
Monte Carlo simulation-based patient-specific QA using machine log files for line-scanning proton radiation therapy
Chanil Jeon1, Jinhyeop Lee1, Jungwook Shin2
1Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Republic of Korea.
Medical Physics
|September 27, 2023
Summary
A new Monte Carlo simulation method for quality assurance in line-scanning proton therapy was developed. This method accurately verifies treatment plans, potentially replacing traditional, labor-intensive measurements.
Area of Science:
- Medical Physics
- Radiation Oncology
- Computational Science
Background:
- Quality assurance (QA) is critical for safe and accurate pencil-beam proton therapy.
- Conventional patient-specific QA (pQA) is limited and labor-intensive, necessitating improved methods.
- Ensuring treatment plan integrity is paramount in advanced proton therapy techniques.
Purpose of the Study:
- To develop and verify a Monte Carlo (MC) simulation-based QA method for line-scanning proton therapy.
- To assess machine performance and its impact on patient treatment accuracy.
- To reflect uncertainties in scanning beam delivery within the QA process.
Main Methods:
- Utilized the Tool for Particle Simulation (TOPAS) for nozzle modeling and commissioned against measurements.
- Acquired beam delivery uncertainty data from log files recorded during patient plan delivery.
- Performed MC simulations in a solid water phantom for 68 clinical cases, comparing 2D dose distributions with ionization chamber array measurements.
- Employed gamma analysis with 3%/3 mm and 2%/2 mm criteria to compare simulated and measured dose distributions.
Main Results:
- Achieved high absolute gamma passing rates (e.g., 96.76% for 2%/2 mm criterion against measurements).
- Demonstrated low standard deviations in passing rates, indicating method consistency (e.g., 3.99% SD for 2%/2 mm criterion).
- Evaluated false-positive and false-negative rates, showing reduction with a 90% passing rate threshold.
Conclusions:
- Successfully developed a log-file-based MC simulation method for patient-specific QA in line-scanning proton therapy.
- The method demonstrated clinically acceptable accuracy, validating its potential.
- Proposed as a replacement for measurement-based dosimetry QA with a 90% gamma passing rate threshold using the 2%/2 mm criterion.

